In a subset of CCA cell lines, Song et al. reported that cyclin D1 overexpression is a major mechanism of acquired resistance to palbociclib (CDK4/6 inhibitor) in intrahepatic CCA cell lines [69]. This evidence concerns the gene CCND1 and cholangiocarcinoma.